$SCYX
SCYNEXIS Inc

2022 Q3 Form 10-Q Financial Statement

#000156459022029486 Filed on August 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $1.557M $1.323M $687.0K
YoY Change 201.74% -94.3%
Cost Of Revenue $189.0K $144.0K $99.00K
YoY Change 30.34%
Gross Profit $1.368M $1.179M $588.0K
YoY Change 268.73%
Gross Profit Margin 87.86% 89.12% 85.59%
Selling, General & Admin $16.74M $15.79M $14.59M
YoY Change 8.62% 23.58% 117.91%
% of Gross Profit 1223.61% 1338.93% 2481.46%
Research & Development $6.430M $7.131M $5.735M
YoY Change 46.1% 50.63% -17.46%
% of Gross Profit 470.03% 604.83% 975.34%
Depreciation & Amortization $150.0K $146.0K $155.0K
YoY Change 212.5% 165.45% 474.07%
% of Gross Profit 10.96% 12.38% 26.36%
Operating Expenses $23.36M $23.06M $20.33M
YoY Change 17.9% 31.72% 48.97%
Operating Profit -$21.80M -$21.74M -$19.74M
YoY Change 12.14% 24.16% 1138.27%
Interest Expense $1.379M $1.231M $9.574M
YoY Change -92.66% 176.63% 4373.83%
% of Operating Profit
Other Income/Expense, Net -$7.783M $8.393M $9.587M
YoY Change -141.43% -44.15% -583.7%
Pretax Income -$29.58M -$13.35M -$10.15M
YoY Change 4416.64% 438.1% 183.86%
Income Tax $0.00 $0.00 -$4.700M
% Of Pretax Income
Net Earnings -$29.58M -$13.35M -$5.451M
YoY Change 4789.92% -904.89% 16.57%
Net Earnings / Revenue -1900.06% -1008.69% -793.45%
Basic Earnings Per Share -$0.62 -$0.31 -$0.17
Diluted Earnings Per Share -$0.62 -$0.31 -$0.18
COMMON SHARES
Basic Shares Outstanding 32.65M 43.29M 32.05M
Diluted Shares Outstanding 47.50M 43.29M 33.19M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $96.09M $118.7M $95.21M
YoY Change -4.01% 5.55% 3.49%
Cash & Equivalents $68.62M $118.7M $95.20M
Short-Term Investments $27.47M
Other Short-Term Assets $4.000K $4.000K $4.000K
YoY Change -98.92% -98.92% -98.92%
Inventory $786.0K $629.0K $1.149M
Prepaid Expenses
Receivables $2.493M $2.211M $1.628M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $103.6M $125.7M $101.9M
YoY Change -0.35% 8.69% 6.82%
LONG-TERM ASSETS
Property, Plant & Equipment $2.646M $2.697M $2.810M
YoY Change -12.24% -13.5% -12.19%
Goodwill
YoY Change
Intangibles $770.0K $866.0K
YoY Change -32.75%
Long-Term Investments
YoY Change
Other Assets $5.076M $6.082M $5.885M
YoY Change 183.73% 236.02% 435.0%
Total Long-Term Assets $8.728M $9.936M $9.656M
YoY Change 46.71% 80.65% 105.45%
TOTAL ASSETS
Total Short-Term Assets $103.6M $125.7M $101.9M
Total Long-Term Assets $8.728M $9.936M $9.656M
Total Assets $112.3M $135.6M $111.6M
YoY Change 2.19% 11.95% 11.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.419M $9.960M $8.130M
YoY Change -1.21% 67.51% 25.08%
Accrued Expenses $5.856M $5.396M $4.523M
YoY Change 27.08% 59.93% 111.95%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $0.00
YoY Change
Total Short-Term Liabilities $14.26M $16.01M $12.94M
YoY Change 7.9% -19.45% -48.02%
LONG-TERM LIABILITIES
Long-Term Debt $45.19M $44.76M $44.53M
YoY Change 14.75% 10.86% 265.0%
Other Long-Term Liabilities $4.898M $5.061M $4.102M
YoY Change 133.35% -82.28% -88.91%
Total Long-Term Liabilities $4.898M $5.061M $4.102M
YoY Change 133.35% -92.66% -91.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.26M $16.01M $12.94M
Total Long-Term Liabilities $4.898M $5.061M $4.102M
Total Liabilities $95.08M $90.13M $72.64M
YoY Change 31.57% 1.49% -2.04%
SHAREHOLDERS EQUITY
Retained Earnings -$407.9M -$378.3M -$364.9M
YoY Change 23.53% 14.78% 10.14%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $17.21M $45.48M $38.93M
YoY Change
Total Liabilities & Shareholders Equity $112.3M $135.6M $111.6M
YoY Change 2.19% 11.95% 11.48%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$29.58M -$13.35M -$5.451M
YoY Change 4789.92% -904.89% 16.57%
Depreciation, Depletion And Amortization $150.0K $146.0K $155.0K
YoY Change 212.5% 165.45% 474.07%
Cash From Operating Activities -$22.51M -$18.58M -$15.99M
YoY Change 35.7% 58.89% 2003.68%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 -$9.000K
YoY Change -100.0% -100.0% -95.5%
Acquisitions
YoY Change
Other Investing Activities -$27.38M
YoY Change
Cash From Investing Activities -$27.38M $0.00 -$9.000K
YoY Change 8000.59% -100.0% -95.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.164M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -183.0K 42.06M 6.723M
YoY Change -104.04% 30.71% -9569.01%
NET CHANGE
Cash From Operating Activities -22.51M -18.58M -15.99M
Cash From Investing Activities -27.38M 0.000 -9.000K
Cash From Financing Activities -183.0K 42.06M 6.723M
Net Change In Cash -50.07M 23.48M 6.714M
YoY Change 304.09% 14.91% -2577.49%
FREE CASH FLOW
Cash From Operating Activities -$22.51M -$18.58M -$15.99M
Capital Expenditures $0.00 $0.00 -$9.000K
Free Cash Flow -$22.51M -$18.58M -$15.98M
YoY Change 38.53% 59.59% 2753.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y5M12D
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Amendment Flag
AmendmentFlag
false
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3071000
CY2022Q2 us-gaap Liabilities
Liabilities
90132000
CY2022Q2 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2022Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
36000
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
423719000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-378275000
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32596403
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32596403
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
45480000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
135612000
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Trading Symbol
TradingSymbol
SCYX
dei Document Type
DocumentType
10-Q
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36365
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Address Address Line2
EntityAddressAddressLine2
13th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Jersey City
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07302-6548
dei City Area Code
CityAreaCode
201
dei Local Phone Number
LocalPhoneNumber
884-5485
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
118691000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
104484000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4145000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3569000
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
866000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1056000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2697000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2801000
CY2022Q2 us-gaap Assets
Assets
135612000
CY2021Q4 us-gaap Assets
Assets
119837000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
9960000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7848000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5396000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5698000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
861000
CY2022Q2 us-gaap Inventory Net
InventoryNet
629000
CY2021Q4 us-gaap Inventory Net
InventoryNet
463000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
109377000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6082000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6235000
CY2021Q4 us-gaap Deferred Costs
DeferredCosts
150000
CY2022Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
218000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
70000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
16012000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13616000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5061000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3345000
CY2022Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
21232000
CY2022Q2 scyx Convertible Debt And Derivative Liability
ConvertibleDebtAndDerivativeLiability
10817000
CY2021Q4 scyx Convertible Debt And Derivative Liability
ConvertibleDebtAndDerivativeLiability
11607000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3204000
CY2021Q4 us-gaap Liabilities
Liabilities
78579000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28705334
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28705334
CY2021Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
32000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
400705000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-359479000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
41258000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
119837000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
525000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-19712000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-16567000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1162000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
372000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2725000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12980000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15786000
us-gaap Operating Lease Payments
OperatingLeasePayments
227000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12050000
scyx Cost Of Product Revenues
CostOfProductRevenues
243000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11682000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
30262000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19468000
us-gaap Operating Expenses
OperatingExpenses
43485000
us-gaap Operating Expenses
OperatingExpenses
31150000
us-gaap Operating Income Loss
OperatingIncomeLoss
-41475000
us-gaap Operating Income Loss
OperatingIncomeLoss
-19100000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2725000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
799000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
525000
us-gaap Interest Income Other
InterestIncomeOther
193000
us-gaap Interest Income Other
InterestIncomeOther
12000
us-gaap Interest Expense
InterestExpense
2291000
us-gaap Interest Expense
InterestExpense
659000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
2000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
2000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26505808
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.50
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
27139760
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15133722
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
500000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2000000.0
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2022Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2021Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1100000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
542000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2022000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
32109000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
14207000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
19404000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93314000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118909000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
112718000
us-gaap Interest Paid Net
InterestPaidNet
1930000
us-gaap Interest Paid Net
InterestPaidNet
511000
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
194000
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
11000
CY2021Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-15300000
dei Entity Central Index Key
EntityCentralIndexKey
0001178253
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2018Q1 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2018Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
us-gaap Debt Instrument Description
DebtInstrumentDescription
0
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y1M2D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y7M2D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M13D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y4M9D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y10M13D
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Registrant Name
EntityRegistrantName
SCYNEXIS, Inc.
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
56-2181648
dei Entity Address Address Line1
EntityAddressAddressLine1
1 Evertrust Plaza
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32651778
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2211000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
125676000
CY2022Q2 us-gaap Deferred Costs
DeferredCosts
73000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
218000
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
457000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
0
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
199000
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
18062000
CY2022Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
33939000
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
28745000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1323000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2010000
CY2022Q2 scyx Cost Of Product Revenues
CostOfProductRevenues
144000
CY2021Q2 scyx Cost Of Product Revenues
CostOfProductRevenues
0
scyx Cost Of Product Revenues
CostOfProductRevenues
0
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7131000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4734000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12774000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
23061000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
17508000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-21738000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-17508000
CY2022Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2022Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
421000
CY2021Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
269000
CY2022Q2 us-gaap Interest Income Other
InterestIncomeOther
181000
CY2021Q2 us-gaap Interest Income Other
InterestIncomeOther
6000
CY2022Q2 us-gaap Interest Expense
InterestExpense
1231000
CY2021Q2 us-gaap Interest Expense
InterestExpense
445000
CY2022Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0
CY2021Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
3000
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-9682000
CY2021Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-15271000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-19712000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-16567000
CY2022Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
182000
CY2021Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
462000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1162000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
372000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8393000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
15028000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
17979000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
13044000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13345000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2480000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23496000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6056000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.50
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4138000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4700000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3038000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-13345000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
1658000
us-gaap Net Income Loss
NetIncomeLoss
-18796000
us-gaap Net Income Loss
NetIncomeLoss
-3018000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.50
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43285232
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26015292
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37647535
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25909457
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43285232
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26487973
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37647535
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26505808
us-gaap Profit Loss
ProfitLoss
-18796000
us-gaap Profit Loss
ProfitLoss
-3018000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
301000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
85000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2022000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
940000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
799000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
104000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
100000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
2248000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-1914000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
4123000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1214000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34569000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12454000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
9000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
251000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-251000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
47153000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3431000
scyx Payments Of Offering Costs And Underwriting Discounts And Commissions
PaymentsOfOfferingCostsAndUnderwritingDiscountsAndCommissions
3352000
scyx Payments Of Offering Costs And Underwriting Discounts And Commissions
PaymentsOfOfferingCostsAndUnderwritingDiscountsAndCommissions
78000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
5000000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
30000000
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
26000
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
1253000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
10000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
9000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
48785000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104702000
us-gaap Stock Issued1
StockIssued1
0
us-gaap Stock Issued1
StockIssued1
7452000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
321000
scyx Deferred Offering Costs Incurred But Not Yet Paid
DeferredOfferingCostsIncurredButNotYetPaid
286000
scyx Deferred Offering Costs Incurred But Not Yet Paid
DeferredOfferingCostsIncurredButNotYetPaid
0
scyx Deferred Offering Costs Reclassified To Additional Paid In Capital
DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital
77000
scyx Deferred Offering Costs Reclassified To Additional Paid In Capital
DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital
0
scyx Reclass Of Warrant Liability To Additional Paid In Capital
ReclassOfWarrantLiabilityToAdditionalPaidInCapital
71000
scyx Reclass Of Warrant Liability To Additional Paid In Capital
ReclassOfWarrantLiabilityToAdditionalPaidInCapital
298000
scyx Reclass Of Deferred Asset Issuance Of Loan Payable To Debt Discount
ReclassOfDeferredAssetIssuanceOfLoanPayableToDebtDiscount
206000
scyx Reclass Of Deferred Asset Issuance Of Loan Payable To Debt Discount
ReclassOfDeferredAssetIssuanceOfLoanPayableToDebtDiscount
390000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-378300000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
118700000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-13345000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
1658000
us-gaap Net Income Loss
NetIncomeLoss
-18796000
us-gaap Net Income Loss
NetIncomeLoss
-3018000
CY2022Q2 scyx Dilutive Securities Effect On Basic Earnings Per Share Warrant Liability
DilutiveSecuritiesEffectOnBasicEarningsPerShareWarrantLiability
0
CY2021Q2 scyx Dilutive Securities Effect On Basic Earnings Per Share Warrant Liability
DilutiveSecuritiesEffectOnBasicEarningsPerShareWarrantLiability
-7415000
scyx Dilutive Securities Effect On Basic Earnings Per Share Warrant Liability
DilutiveSecuritiesEffectOnBasicEarningsPerShareWarrantLiability
0
scyx Dilutive Securities Effect On Basic Earnings Per Share Warrant Liability
DilutiveSecuritiesEffectOnBasicEarningsPerShareWarrantLiability
-8739000
CY2022Q2 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0
CY2021Q2 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0
us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0
us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-13345000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-5757000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-18796000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-11757000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43285232
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26015292
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37647535
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25909457
CY2022Q2 scyx Incremental Common Shares Attributable To Warrant Liabilities
IncrementalCommonSharesAttributableToWarrantLiabilities
0
CY2021Q2 scyx Incremental Common Shares Attributable To Warrant Liabilities
IncrementalCommonSharesAttributableToWarrantLiabilities
472681
scyx Incremental Common Shares Attributable To Warrant Liabilities
IncrementalCommonSharesAttributableToWarrantLiabilities
0
scyx Incremental Common Shares Attributable To Warrant Liabilities
IncrementalCommonSharesAttributableToWarrantLiabilities
596351
CY2022Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
CY2021Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43285232
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26487973
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37647535
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
27139760
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15133722
CY2022Q2 scyx Accrued Rebates Current
AccruedRebatesCurrent
896000
CY2021Q4 scyx Accrued Rebates Current
AccruedRebatesCurrent
836000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="margin-bottom:6pt;margin-top:0pt;text-indent:4.15%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#F9F9F9;">Reclassification of Prior Year Amounts</span></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.15%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#F9F9F9;">Certain prior year amounts have been reclassified for consistency with the current year presentation.</span></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.15%;font-size:10pt;"> </p>
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
23874000
CY2022Q2 scyx Prepaid Researchand Development Expenses Current
PrepaidResearchandDevelopmentExpensesCurrent
498000
CY2021Q4 scyx Prepaid Researchand Development Expenses Current
PrepaidResearchandDevelopmentExpensesCurrent
247000
CY2022Q2 us-gaap Prepaid Insurance
PrepaidInsurance
727000
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
505000
CY2022Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
2916000
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
2813000
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
4000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4145000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3569000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5396000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5698000
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
11126000
CY2022Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
35000000
CY2022Q2 scyx Debt Instrument Final Fee Due At Maturity
DebtInstrumentFinalFeeDueAtMaturity
1383000
CY2022Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
36383000
CY2022Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5495000
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5162000
CY2022Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
20000
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3000
CY2022Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
100000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
127000
CY2022Q2 scyx Inventory Current And Noncurrent Net
InventoryCurrentAndNoncurrentNet
5615000
CY2021Q4 scyx Inventory Current And Noncurrent Net
InventoryCurrentAndNoncurrentNet
5292000
CY2022Q2 scyx Accrued Researchand Development Expense Current
AccruedResearchandDevelopmentExpenseCurrent
1118000
CY2021Q4 scyx Accrued Researchand Development Expense Current
AccruedResearchandDevelopmentExpenseCurrent
1498000
CY2022Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1159000
CY2021Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2012000
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2223000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1352000
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0
CY2022Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
2444000
CY2022Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
0
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
33939000
CY2018Q1 scyx Lease Agreement Area Of Office Space
LeaseAgreementAreaOfOfficeSpace
19275
CY2018Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P11Y
CY2018Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
7300000
us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
The Company has the option to renew for two consecutive five-year periods from the end of the first term and the Company is not reasonably certain that the option to renew the Lease will be exercised. Under the Lease, the Company furnished a security deposit in the form of a standby letter of credit in the amount of $0.3 million, which was reduced by fifty-five thousand dollars on the first anniversary of the commencement date.  The security deposit will continue to be reduced by fifty-five thousand dollars every two years on the commencement date anniversary for eight years.
CY2018Q1 us-gaap Security Deposit
SecurityDeposit
300000
CY2018Q1 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
55000
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
166000
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
166000
us-gaap Operating Lease Cost
OperatingLeaseCost
332000
us-gaap Operating Lease Cost
OperatingLeaseCost
332000
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
8000
CY2021Q2 us-gaap Variable Lease Cost
VariableLeaseCost
10000
us-gaap Variable Lease Cost
VariableLeaseCost
5000
us-gaap Variable Lease Cost
VariableLeaseCost
9000
CY2022Q2 us-gaap Lease Cost
LeaseCost
174000
CY2021Q2 us-gaap Lease Cost
LeaseCost
176000
us-gaap Lease Cost
LeaseCost
337000
us-gaap Lease Cost
LeaseCost
341000
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
58000
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
57000
us-gaap Operating Lease Payments
OperatingLeasePayments
232000
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.15
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.15
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
45480000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
22758000
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
71000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
296000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
715000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
730000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
744000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
759000
CY2022Q2 scyx Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
2030000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5274000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
3270000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
199000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3071000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
3270000
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2004000
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32596403
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32596403
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28705334
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28705334
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
38927000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-13345000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1100000
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
18798000
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
45480000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
25924000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
1658000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
542000
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3415000
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
15000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
766000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
32320000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
41258000
us-gaap Net Income Loss
NetIncomeLoss
-18796000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2022000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
10000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
20915000
us-gaap Net Income Loss
NetIncomeLoss
-3018000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
940000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
9000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3412000
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
766000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
32320000
CY2022Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
42168597
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
14367493
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-9700000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-19700000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-16600000
CY2022Q2 scyx Fair Value Of Liabilities
FairValueOfLiabilities
21200000
CY2021Q4 scyx Fair Value Of Liabilities
FairValueOfLiabilities
18100000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1542126
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.89
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
42000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
647000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.20
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
60124
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
8.15
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2129002
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.83
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
955116
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
19.24
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2129002
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
11.83
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
5000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1100000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
900000
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
940000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1380000
scyx Contract With Customer Liability Provision Related To Current Period Revenue
ContractWithCustomerLiabilityProvisionRelatedToCurrentPeriodRevenue
2944000
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
0
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2605000
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1719000

Files In Submission

Name View Source Status
0001564590-22-029486-index-headers.html Edgar Link pending
0001564590-22-029486-index.html Edgar Link pending
0001564590-22-029486.txt Edgar Link pending
0001564590-22-029486-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
scyx-10q_20220630.htm Edgar Link pending
scyx-20220630.xsd Edgar Link pending
scyx-ex101_42.htm Edgar Link pending
scyx-ex311_8.htm Edgar Link pending
scyx-ex312_7.htm Edgar Link pending
scyx-ex321_6.htm Edgar Link pending
Show.js Edgar Link pending
scyx-20220630_def.xml Edgar Link unprocessable
scyx-20220630_lab.xml Edgar Link unprocessable
scyx-20220630_pre.xml Edgar Link unprocessable
scyx-10q_20220630_htm.xml Edgar Link completed
scyx-20220630_cal.xml Edgar Link unprocessable